Cagrilintidehe mahi roa, kua whakahiatotia matūte agonist kaiawhina amylin, i whakawhanakehia hei maimoatanga hou momōmona me te mate pākia e pā ana ki te taumaha. Kua hoahoatia hei whakatauira i nga paanga oamylin tangata, he homoni i huna tahi me te insulin e nga pūtau β-pancreatic, he mahi nui ki te whakahaere i te kai, te putunga puku, me te makona.
Kei te whakawhanakehia te Cagrilintide hei akotahi-wiki te rongoa injectable, tuku he otinga tino pai mote whakahaere taimaha roa, ina koa ka whakamahia i rotote whakakotahitanga me nga agonists kaiawhina GLP-1peneiSemaglutide.
Ka whakamahia e te Cagrilintide ona hua rongoa ma te here me te whakahohenga kaiwhakawhiwhi amylin, ka arahi ki:
Te whakakore i te hiahia
Kua roa te putunga o te kopu, e whakaroa ana i te ahua o te ki tonu
Kua whakaitihia te kai o te kaarai me te whakanui ake i te makona
Ko tenei ture maha mo te kai kai ka waiho hei kaitono pai mo te whakahaeremōmona me ngā mōrea cardiometabolic pātahi.
Kua whakaatuhia e Cagrilintide nga hua pai i roto i te maha o nga whakamatautau haumanu, tae atu kiWāhanga 2 rangahau i whakahaerehia e Novo Nordisk:
Ina whakamahiaanake, Cagrilintide arata'i kimate taimaha e whakawhirinaki ana ki te horopeta, tae noa ki10.8% te whakaheke taimaha tinananeke atu i te 26 wiki ki te hunga momomomo.
Inakua honoa ki a Semaglutide, ka tino whakanuia te paanga o te mate taimaha—te whakatutukihe nui ake te whakahekenga o te taumaha o te tinana i te kaihoko anake.
Kua whakaatute pai o te manawanuiahe pūkete haumaru pūmau, me te nuinga o nga mea kino he tohu ngawari o te gastrointestinal.
Ko tenei huarahi whakakotahi he waahanga nui o tepaipa tarukino anti-momona whakatupuranga muri, e aro ana ki nga ara makona maha (amylin + GLP-1).
To tatouCagrilintide API:
Ka whakaputahia ma te matataute whakahiato peptide-waa toka (SPPS)me te tino parakore me te pumau matū
Kua hoahoa mowhanaketanga hanga injectable
Ka tutaki ki te aonga paerewa rongoa (ICH, GMP, FDA)
Kei te waatea i rotote kaiurungi ki te hanga tauine arumoni, he pai mo te mahi haumanu me te ahumahi
Ko te Cagrilintide te tohu atikanga houi roto i te whakahaere taumaha i tua atu i te GLP-1 monotherapy. Ko tana tohu mahi taapiri e pai ana mo:
Nga turoro me te taumaha nui(me te mate huka kore ranei)
Te rongoa whakakotahimo te whakapai ake i te mate taimaha
Te whanaketanga a meake nei i roto imate metabolic me te prediabetes